{ "items": [ "\n\n
\n \n 22 February 2023\n \n
\n\n \n\n \n\n \n \n \n \n OCTRU\n \n \n\n \n\n\n
\n \n\n \n \n \n \n \n\n\n \n 17 February 2023\n \n
\n\n \n\n \n\n \n \n \n \n OCTRU\n \n \n\n \n\n\n
\n \n\n \n \n \n \n \n\n\n \n 4 January 2023\n \n
\n\n \n\n \n\n \n \n \n \n OCTRU\n \n \n\n \n\n\n
\n \n\n \n \n \n \n \n\n\n \n 15 November 2022\n \n
\n\n \n\n \n\n \n \n \n \n OCTRU\n \n \n\n \n\n\n
\n \n\n \n \n \nResearchers at the Kennedy Institute of Rheumatology and Oxford Population Health\u2019s Health Economics Research Centre have found that anti-TNF treatment (adalimumab) is likely to be a cost-effective treatment for people affected by early-stage Dupuytren\u2019s disease.
\n \n\n\n \n 4 October 2022\n \n
\n\n \n\n \n\n \n \n \n \n OCTRU\n \n \n\n \n\n\n
\n \n\n \n \n \nCongratulations to Professor Tim Theologis, who has been awarded three NIHR HTA grants to extend research in orthopaedic disorders in children.
\n \n\n\n \n 28 September 2022\n \n
\n\n \n\n \n\n \n \n \n \n OCTRU\n \n \n\n \n\n\n
\n \n\n \n \n \n \n \n\n\n \n 23 August 2022\n \n
\n\n \n\n \n\n \n \n \n \n OCTRU\n \n \n\n \n\n\n
\n \n\n \n \n \nNew research, funded by the National Institute for Health and Care Research (NIHR), shows initial surgery to be more successful and cost effective than undergoing treatment with rehabilitation first to treat longstanding anterior cruciate ligament injury.
\n \n\n\n \n 23 August 2022\n \n
\n\n \n\n \n\n \n \n \n \n OCTRU\n \n \n\n \n\n\n
\n \n\n \n \n \n \n \n\n\n \n 27 July 2022\n \n
\n\n \n\n \n\n \n \n \n \n OCTRU\n \n \n\n \n\n\n
\n \n\n \n \n \nResearchers at the University of Oxford have been awarded a grant from the National Institute for Health and Care Research (NIHR) to investigate whether anti-tumour necrosis factor (TNF) therapy can reduce or prevent post operative delirium/cognitive deficit.
\n \n\n\n \n 6 July 2022\n \n
\n\n \n\n \n\n \n \n \n \n OCTRU\n \n \n\n \n\n\n
\n \n\n \n \n \nNew research from the University of Oxford has shown that doctors can simplify treatment for the most common fracture in children, reducing NHS costs.
\n \n\n\n \n 29 June 2022\n \n
\n\n \n\n \n\n \n \n \n \n OCTRU\n \n \n\n \n\n\n
\n \n\n \n \n \nThe Oxford Clinical Trials Research Unit (OCTRU) at NDORMS played a key role in the VROOM study which found that pausing immune-suppressing medicines such as methotrexate can increase the response to COVID-19 booster jabs.
\n \n\n\n \n 20 May 2022\n \n
\n\n \n\n \n\n \n \n \n \n OCTRU\n \n \n\n \n\n\n
\n \n\n \n \n \nTo mark Clinical Trials Day we take a look at some of the recent developments at NDORMS and celebrate the teams that make this important area of our research programme possible.
\n \n\n\n \n 30 April 2022\n \n
\n\n \n\n \n\n \n \n \n \n OCTRU\n \n \n\n \n\n\n
\n \n\n \n \n \nInjection of the anti-TNF drug adalimumab into Dupuytren\u2019s disease nodules is effective in reducing nodule hardness and nodule size.
\n \n\n\n \n 6 April 2022\n \n
\n\n \n\n \n\n \n \n \n \n OCTRU\n \n \n\n \n\n\n
\n \n\n \n \n \nA new study published in JAMA, has found that a drug recently licensed in the UK has no effect on post-operative knee replacement recovery or pain, compared to the current treatment when administered at site of surgery.
\n \n\n\n \n 4 April 2022\n \n
\n\n \n\n \n\n \n \n \n \n OCTRU\n \n \n\n \n\n\n
\n \n\n \n \n \n \n \n\n\n \n 10 February 2022\n \n
\n\n \n\n \n\n \n \n \n \n OCTRU\n \n \n\n \n\n\n
\n \n\n \n \n \nThe White 5 trial compared implants fixed with bone cement against uncemented implants for hip fractures treated with hemiarthroplasty.
\n \n\n\n \n 2 February 2022\n \n
\n\n \n\n \n\n \n \n \n \n OCTRU\n \n \n\n \n\n\n
\n \n\n \n \n \nFUTURE-GB has bounced into 2022 ahead of both predicted recruitment into Stage 2 (the Randomised Controlled Trial), and the sites open in Stage 2! Congratulations to all our sites for their hard work so far.
\n \n\n\n \n 31 January 2022\n \n
\n\n \n\n \n\n \n \n \n \n OCTRU\n \n \n\n \n\n\n
\n \n\n \n \n \n \n \n\n\n \n 19 January 2022\n \n
\n\n \n\n \n\n \n \n \n \n OCTRU\n \n \n\n \n\n\n
\n \n\n \n \n \nAn Oxford study published in The BMJ has found the use of metal K-wires (commonly known as \u2018pins\u2019) to hold broken wrist bones in place while they heal are no better than a traditional moulded plaster cast.
\n \n\n\n \n 11 January 2022\n \n
\n\n \n\n \n\n \n \n \n \n OCTRU\n \n \n\n \n\n\n
\n \n\n \n \n \n \n \n\n